Zimmer Biomet (ZBH) Group President Kevin R. Thornal Receives RSU Shares

What Happened
Kevin R. Thornal, Group President—Global Business at Zimmer Biomet (ZBH), had 9,957 restricted stock units (RSUs convertable to common shares) vest on August 1, 2026. The RSUs were converted into shares (reported as derivative exercise/conversion). The company withheld 4,266 shares to satisfy tax withholding obligations at $92.68 per share (total withheld value about $395,373), leaving a net delivery of 5,691 shares to Thornal. This was a vesting/settlement of awards, not an open-market purchase or sale.

Key Details

• Transaction date: August 1, 2026; filing date: August 4, 2026.
• Vesting/conversion: 9,957 RSUs converted to shares (code M in the filing).
• Tax withholding: 4,266 shares withheld (code F) at $92.68/share = $395,373.
• Net shares delivered to insider: 9,957 − 4,266 = 5,691 shares.
• Footnotes: F1: shares withheld to satisfy tax withholding; F2: each RSU = one share; F3: one‑third of the RSUs vested Aug 1, 2026, remainder vests half on Aug 1, 2027 and Aug 1, 2028.
• Shares owned after transaction: total holdings after this transaction are not disclosed in the filing.

Context
This was a routine RSU vesting and net share settlement (company withheld shares to cover taxes), not a market sale or purchase. For retail investors, vesting and withholding are administrative—useful to track insider compensation and future vesting schedule but not a direct bullish/bearish trade signal.